SIGLEC5 and infection: In fact, Siglec‐14 has been shown to counteract the exploitation of Siglec‐5 by GBS (Ali et al., 2014), and Siglec‐16 reduces survival of E. coli K1 during infection (Schwarz et al., 2017).